The effect of Lazarus multimodal therapy on depression, anxiety, and blood glucose control in women with type 2 diabetes

Considering the interactions between depression and anxiety on the increase in blood glucose in diabetic patients and the need for intervention to improve these variables, the aim of this study was to investigate the effectiveness of Lazarus multimodal therapy on reducing the symptoms of depression, anxiety and glycemic control in women with type 2 diabetes.
In this study, which was performed on women with type 2 diabetes with high score in depression and anxiety and glycosylated hemoglobin (HbA1C) level more than 7%, 24 subjects who entered the study were selected by convenient method and they were randomly assigned into two groups of experimental and control (each group included 12 subjects). Research instrument include Beck Depression Inventory-II, Beck Anxiety Inventory and glycosylated hemoglobin. The experimental group was trained at Lazarus multimodal psychotherapy group workshop for three months (12 weekly ninety-minute sessions) in the spring and summer of 2016 at Samen Health Center- Mashhad. The control group was in the waiting list. Also, multivariate analysis of covariance analysis was used to analyze the data through SPSS software.
The results of this study showed that Lazarus multidimodal therapy significantly (P=0.001) reduced the symptoms of depression, anxiety and decreased blood glucose levels in women with type 2 diabetes compared to control group.
Totally based on the findings, Lazarus multidimodal therapy can be effective to reduce the symptoms of anxiety, depression and physical symptoms among diabetic patients.